You’re doing a Q-bank and get a cervical cancer question… and it feels “too easy.” HPV. Pap smear. Vaccine. Move on. But the real score gains come from understanding why each wrong answer is wrong—because NBME-style questions love swapping in near-miss distractors (HSV, EBV, adenovirus, polyomavirus, etc.). Let’s break down a classic vignette the way you should in your head on test day.
Clinical Vignette (Q-bank style)
A 32-year-old woman presents for routine screening. She has had multiple sexual partners and inconsistent condom use. Her Pap smear shows koilocytosis. Colposcopy reveals a high-grade lesion. Biopsy demonstrates dysplasia involving the full thickness of the epithelium. Which of the following best explains the pathogenesis of this condition?
A. Viral E6 and E7 proteins inactivate p53 and Rb tumor suppressor proteins
B. Viral thymidine kinase allows replication in nondividing cells
C. Virus establishes latency in sensory ganglia with periodic reactivation
D. Viral integration causes constitutive activation of NF-κB via Tax protein
E. Virus infects B cells and drives polyclonal activation via CD21 binding
Step-by-Step: What the Stem Is Screaming
Key clues
- Koilocytosis → classic for HPV infection (perinuclear clearing + nuclear atypia)
- High-grade lesion + full thickness dysplasia → CIN III / carcinoma in situ
- Risk factors: multiple partners, inconsistent barrier protection
Diagnosis shortcut
HPV (especially 16, 18) → cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Correct Answer: A. E6 and E7 inactivate p53 and Rb
High-risk HPV types (most famously 16 and 18, also 31, 33, 45) are oncogenic because they disrupt cell-cycle checkpoints:
The two viral oncoproteins you must know
- E6 → binds/inactivates p53 → ↓ apoptosis + impaired DNA damage arrest
- Also increases telomerase (hTERT) activity (high-yield association)
- E7 → binds/inactivates Rb → releases E2F → pushes cell into S phase
Why integration matters (high-yield nuance)
- In high-risk HPV, viral DNA often integrates into the host genome.
- Integration disrupts the E2 gene (a regulator that normally restrains E6/E7), leading to overexpression of E6/E7 → malignant progression.
What You’re Expected to Recognize (HPV High-Yield)
HPV basics (USMLE-friendly)
- Nonenveloped, icosahedral, dsDNA virus
- Replicates in the nucleus
- Causes:
- Anogenital warts (low-risk types 6, 11)
- Cervical cancer (high-risk types 16, 18)
- Other cancers: oropharyngeal squamous cell carcinoma (esp. HPV-16)
Koilocytes = buzzword
- Squamous epithelial cells with:
- Perinuclear halo
- Enlarged, hyperchromatic nuclei
Distractor Autopsy: Why Each Wrong Answer Is Wrong
B. Viral thymidine kinase allows replication in nondividing cells
This is pointing to HSV (and to a lesser extent VZV).
- HSV has thymidine kinase, which is why acyclovir works (it’s phosphorylated by viral TK).
- HPV does not rely on thymidine kinase as its defining feature.
- HPV’s oncogenesis is driven by E6/E7, not by a drug-target enzyme.
Test-day tip: If you see “thymidine kinase” in an answer choice, your brain should immediately think HSV/VZV + acyclovir.
C. Virus establishes latency in sensory ganglia with periodic reactivation
Also classic HSV (and VZV).
- HSV-1: trigeminal ganglia
- HSV-2: sacral ganglia
- VZV: dorsal root ganglia
HPV does infect basal epithelial cells and can persist, but it’s not a “sensory ganglion latency/reactivation” virus.
How they trick you: Cervical lesions + STI risk factors can bait HSV, but HSV is more about painful vesicular lesions, not koilocytosis/CIN.
D. Viral integration causes constitutive activation of NF-κB via Tax protein
This is HTLV-1.
- HTLV-1 is an enveloped ssRNA retrovirus (diploid), uses reverse transcriptase
- Tax activates transcription (including IL-2) and promotes T-cell proliferation
- Associated with:
- Adult T-cell leukemia/lymphoma
- Tropical spastic paraparesis
HPV integrates too, but Tax/NF-κB is not HPV’s mechanism. HPV’s key proteins are E6/E7.
E. Virus infects B cells and drives polyclonal activation via CD21 binding
This is EBV.
- EBV infects B cells via CD21 (CR2)
- Causes:
- Infectious mononucleosis (posterior cervical LAD, splenomegaly)
- Burkitt lymphoma (t(8;14), c-myc)
- Hodgkin lymphoma (some cases)
- Nasopharyngeal carcinoma
Cervical squamous dysplasia/cancer is not driven by EBV; it’s an HPV story.
Another classic EBV distractor: “heterophile-positive” or “atypical lymphocytes (reactive CD8+ T cells)” would steer you to EBV—not here.
Rapid-Fire Comparison Table (Great for Elimination)
| Virus | Genome/Envelope | Key Mechanism/Buzzword | Classic Diseases |
|---|---|---|---|
| HPV (16/18) | dsDNA, nonenveloped | E6 (p53), E7 (Rb); koilocytes | CIN, cervical cancer, oropharyngeal SCC |
| HPV (6/11) | dsDNA, nonenveloped | Benign proliferation | Condyloma acuminata, laryngeal papillomas |
| HSV-1/2 | dsDNA, enveloped | Latency in sensory ganglia; viral TK | Painful vesicles, encephalitis (HSV-1), neonatal herpes (HSV-2) |
| EBV | dsDNA, enveloped | Infects B cells via CD21 | Mono, Burkitt, some Hodgkin, NPC |
| HTLV-1 | ssRNA-RT, enveloped | Tax → T-cell proliferation | Adult T-cell leukemia/lymphoma |
USMLE High-Yield Add-Ons (Common Follow-Up Questions)
1) Screening logic (Step 2 vibe)
- Pap screening typically starts at age 21 (US guidelines commonly tested in broad strokes)
- HPV testing co-testing increases with age (details vary by guideline updates—know the general principle: screen + triage)
2) Vaccine points (Step 1 + Step 2)
- Gardasil 9 protects against:
- High-risk: 16, 18, 31, 33, 45, 52, 58
- Low-risk: 6, 11
- It’s prophylactic, not therapeutic (prevents infection; doesn’t treat established lesions)
3) Morphology and progression (path tie-in)
- CIN I: lower 1/3 of epithelium (often transient HPV)
- CIN II/III: increasing thickness involvement, higher malignant potential
- Carcinoma in situ (CIN III): full thickness dysplasia, basement membrane intact
- Invasive cancer crosses the basement membrane
Take-Home “Answer Choice Mindset”
When the stem gives you koilocytosis + cervical dysplasia, lock onto HPV—then choose the mechanism that matches high-risk HPV oncogenesis:
- High-risk HPV → E6 inhibits p53; E7 inhibits Rb
- Everything else is a “different virus with a different signature move.”
If you train yourself to recognize what each distractor is trying to be, you’ll start getting questions right even when the stem is messy.